Neuropsychological Evaluations in Adults - American Family Physician
Jan 15, 2019 - Neuropsychologists provide detailed assessments of cognitive and emotional functioning that often cannot be obtained through other diagnostic means. They use standardized assessment tools and integrate the findings with other data to determine whether cognitive decline has occurred, to ...
American Family Physician : Article
https://www.aafp.org/afp/2019/0115/p101.html
Cerebrospinal Fluid Biomarkers for Detection of Alzheimer Disease in Patients with Mild...
Jun 1, 2018 - There is insufficient evidence to support the routine use of cerebrospinal fluid (CSF) biomarkers for the detection of progressive dementias in patients with mild cognitive impairment (MCI). These tests carry the risk of overdiagnosis of dementia and, therefore, overtreatment.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2018/0601/p714.html
Short-Term Antipsychotics for Alzheimer Disease - FPIN's Help Desk Answers - American ...
Apr 1, 2018 - Physicians should consider not using antipsychotics in patients with dementia. Patients with dementia, including Alzheimer disease, who are treated with antipsychotics for any length of time have a higher mortality rate than those not taking antipsychotics.
American Family Physician : FPIN's Help Desk Answers
https://www.aafp.org/afp/2018/0401/od2.html
Evaluation of Suspected Dementia - American Family Physician
Mar 15, 2018 - Dementia is a significant and costly health condition that affects 5 million adults and is the fifth leading cause of death among Americans older than 65 years. The prevalence of dementia will likely increase in the future because the number of Americans older than 65 years is expected ...
American Family Physician : Article
https://www.aafp.org/afp/2018/0315/p398.html
Page 1